Activity of abundant antimicrobials of the human airway (Q33860518)

29 July 2017

title

Activity of abundant antimicrobials of the human airway (English)

1 reference

29 July 2017

author

Everett Peter Greenberg

7

object named as

Greenberg EP

1 reference

29 July 2017

Travis SM

1

1 reference

29 July 2017

Conway BA

2

1 reference

29 July 2017

Zabner J

3

1 reference

29 July 2017

Smith JJ

4

1 reference

29 July 2017

Anderson NN

5

1 reference

29 July 2017

Singh PK

6

1 reference

29 July 2017

Welsh MJ

8

1 reference

29 July 2017

publication date

1 May 1999

1 reference

American Journal of Respiratory Cell and Molecular Biology

29 July 2017

published in

1 reference

29 July 2017

volume

20

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

872-879

1 reference

On a Remarkable Bacteriolytic Element Found in Tissues and Secretions

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Distribution of secretory leukoprotease inhibitor in the human nasal airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Human airway epithelia express a beta-defensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Production of beta-defensins by human airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Microbiology of airway disease in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

A sensitive defense: salt and cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

The susceptibility to lysozyme of beta-lactamase-producing and non-producing derivatives of Staphylococcus aureus strain 1030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Human beta-defensin-1: an antimicrobial peptide of urogenital tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

On the use of absorbing discs to sample mucosal surface liquids

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Elemental composition of human airway surface fluid in healthy and diseased airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Estimation of nasal epithelial lining fluid using urea as a marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Burkholderia cepacia: medical, taxonomic and ecological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

Alterations in outer membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.20.5.3572

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.20.5.3572

1 reference

29 July 2017

1 reference